Blackham A and Griffiths RJ |
The effect of FK506 and cyclosporin A on antigen-induced arthritis. |
1991 |
Clin. Exp. Immunol. |
pmid:1718639
|
Kobayashi N et al. |
Significance of pancreatic allograft rejection in swine abdominal organ cluster transplantation. |
1991 |
Transplant. Proc. |
pmid:1703707
|
Strasser S et al. |
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs. |
1991 |
Transplant. Proc. |
pmid:1703709
|
Ryu S and Yasunami Y |
Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump. |
1991 |
Transplant. Proc. |
pmid:1703710
|
Alejandro R et al. |
Combined liver-islet allotransplantation in man under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703712
|
Abu-Elmagd KM et al. |
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. |
1991 |
Transplant. Proc. |
pmid:1721272
|
Ericzon BG et al. |
Pharmacokinetics of FK 506 during maintenance therapy in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721273
|
Jain AB et al. |
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721274
|
McMichael J et al. |
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721275
|
Connelly PR |
Thermodynamics of interaction of FK 506-binding protein and its ligands. |
1991 |
Transplant. Proc. |
pmid:1721304
|
Donnelly JG and Soldin SJ |
Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721305
|
Rosborough SL et al. |
Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography. |
1991 |
Transplant. Proc. |
pmid:1721306
|
Zeevi A et al. |
In vitro assessment of FK 506 immunosuppressive activity in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721307
|
Lewis WD et al. |
FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. |
1991 |
Transplant. Proc. |
pmid:1721336
|
Woodle ES et al. |
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721337
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
McDiarmid SV et al. |
FK 506 rescue therapy in liver transplantation: outcome and complications. |
1991 |
Transplant. Proc. |
pmid:1721339
|
Darras FS et al. |
Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721368
|
Todo S et al. |
Clinical small bowel or small bowel plus liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721369
|
Fries D et al. |
Development of renal dysfunction and renal histological lesions in two patients treated with FK 506 for acute rejection following liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721370
|
Wijnen RM et al. |
Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels. |
1991 |
Transplant. Proc. |
pmid:1721371
|
Christians U et al. |
Measurement of FK 506 by HPLC and isolation and characterization of its metabolites. |
1991 |
Transplant. Proc. |
pmid:1703358
|
Lagodziński Z et al. |
Effect of FK 506 on B-cell responses. |
1991 |
Transplant. Proc. |
pmid:1703359
|
Demetris AJ et al. |
Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703360
|
Abu-Elmagd KM et al. |
Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721404
|
Adams CK and Famili P |
A study of the effects of the drug FK 506 on gingival tissues. |
1991 |
Transplant. Proc. |
pmid:1721405
|
Pirsch JD et al. |
Pulmonary infiltrates and eosinophilia in an FK 506 liver transplant recipient. |
1991 |
Transplant. Proc. |
pmid:1721406
|
Shinozuka H et al. |
Effect of FK 506 on experimental liver carcinogenesis. |
1991 |
Transplant. Proc. |
pmid:1721407
|
Pelekanou V et al. |
FK 506 and rapamycin do not affect platelet aggregation or mitochondrial function. |
1991 |
Transplant. Proc. |
pmid:1721408
|
Griffiths EJ and Halestrap AP |
Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. |
1991 |
Biochem. J. |
pmid:1706598
|
Brabletz T et al. |
The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. |
1991 |
Nucleic Acids Res. |
pmid:1707162
|
Iwaki Y et al. |
Replacement of donor lymphoid tissue in small-bowel transplants. |
1991 |
Lancet |
pmid:1707470
|
Ito T et al. |
Bone marrow cell- and FK 506-induced donor-specific unresponsiveness in rat heart allografts. |
1991 |
Transplant. Proc. |
pmid:1721437
|
DeValeria PA et al. |
FK 506 fails to reverse moderate cardiac allograft rejection in a canine heterotopic model. |
1991 |
Transplant. Proc. |
pmid:1721438
|
Jiang H et al. |
Prolonged cardiac allograft survival in sensitized rats by low-dose FK 506 in combination with splenectomy. |
1991 |
Transplant. Proc. |
pmid:1721439
|
Sato K et al. |
Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine. |
1991 |
Transplant. Proc. |
pmid:1721440
|
McAlpine JB et al. |
Revised NMR assignments for rapamycin. |
1991 |
J. Antibiot. |
pmid:1712766
|
Banerji SS et al. |
The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1. |
1991 |
Mol. Cell. Biol. |
pmid:1712901
|
Markus PM et al. |
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. |
1991 |
Surgery |
pmid:1713358
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Nicoletti F et al. |
FK-506 prevents diabetes in diabetes-prone BB/Wor rats. |
1991 |
Int. J. Immunopharmacol. |
pmid:1722192
|
Starzl TE et al. |
[Clinical experience with FK 506]. |
1991 |
Presse Med |
pmid:1722311
|
Granelli-Piperno A and McHugh P |
Characterization of a protein that regulates the DNA-binding activity of NF-AT, the nuclear factor of activated T cells. |
1991 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:1722332
|
Nelson PA et al. |
cDNA encoding murine FK506-binding protein (FKBP): nucleotide and deduced amino acid sequence. |
1991 |
Gene |
pmid:1722474
|
Nakahama H et al. |
Comparative effects of cyclosporine A and FK-506 on endothelin secretion by a cultured renal cell line, LLC-PK1. |
1991 |
J. Cardiovasc. Pharmacol. |
pmid:1725322
|
Romanowski P et al. |
[Synthetic immunomodulators designed on the basis of natural products of microorganisms]. |
1991 |
Postepy Biochem. |
pmid:1725924
|
Altmeyer A et al. |
Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin. |
1991 |
Int. J. Immunopharmacol. |
pmid:1726093
|
Gordon RD et al. |
Liver transplantation at the University of Pittsburgh, 1984 to 1990. |
1991 |
Clin Transpl |
pmid:1726458
|
Lane WS et al. |
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. |
1991 |
J. Protein Chem. |
pmid:1718307
|
James DG |
Which immunomodulator? |
1991 |
Br J Clin Pract |
pmid:1718384
|